CATALYST PHARMACEUTICALS, INC. (CPRX) › Operating Cash FlowCATALYST PHARMACEUTICALS, INC. (CPRX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$7.68M2010: -$3.76M2011: -$4.99M2012: -$5.14M2017: -$13.74M2018: -$26.15M2019: $34.61M2020: $45.03M2021: $60.37M2022: $116.05M2023: $143.60M2024: $239.81M2025: $208.67M$208.67M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$208.67M-13.0%2024$239.81M+67.0%2023$143.60M+23.7%2022$116.05M+92.2%2021$60.37M+34.1%2020$45.03M+30.1%2019$34.61M+232.4%2018-$26.15M-90.3%2017-$13.74M—2012-$5.14M-3.1%2011-$4.99M-32.7%2010-$3.76M+51.1%2009-$7.68M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share